Jazz: 24/7 production shifts could help stem Erwinaze shortage
Non-stop production shifts are among initiatives being tested by Jazz Pharmaceuticals to up supply of orphan drug Erwinaze after its CMO received an FDA warning letter.
Archives for March 1, 2017
UK makes validated stem cells available to therapy developers for £500 per vial
Cell therapy developers can source “regulator ready” stem cells from the UK Stem Cell Bank (UKSCB) for a £500 per vial fee under a scheme announced by the MHRA.